Syndax Pharmaceuticals Inc Cash Flow Quality Index
Syndax Pharmaceuticals Inc cash flow quality index. Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Quality Index of 1.05x as of December 2021. Operating cash flow of $100.71 Million exceeds net income of $96.20 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of Syndax Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Syndax Pharmaceuticals Inc (2021–2021)
Cash flow quality index of Syndax Pharmaceuticals Inc from 2021 to 2021. Historical Cash Flow Quality Index for Syndax Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Syndax Pharmaceuticals Inc (SNDX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Syndax Pharmaceuticals Inc Cash Flow Quality Index by Year (2021–2021)
Syndax Pharmaceuticals Inc cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Syndax Pharmaceuticals Inc. For the full cash flow conversion analysis, see Syndax Pharmaceuticals Inc cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.17x | $29.13 Million | $24.93 Million | — |